alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
##### 



EXHIBIT 31.1
 CERTIFICATION PURSUANT TO
EXCHANGE ACT RULE 13a-14(a)
  1.
    
    I have reviewed this Report on Form 10-Q of International Absorbents Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the periods presented in this
report;4.
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) for the registrant and have:
 (a)
    
    Designed such disclosure controls and procedures, or caused such disclosure
controls and procedures to be designed under our supervision, to ensure that material
information relating to the registrant, including its consolidated subsidiaries, is
made known to us by others within those entities, particularly during the period in
which this report is being prepared;(b)
    
    Evaluated the effectiveness of the registrants disclosure controls and
procedures and presented in this report our conclusions about the effectiveness of the
disclosure controls and procedures, as of the end of the period covered by this report
based on such evaluation; and(c)
    
    Disclosed in this report any change in the registrants internal control over
financial reporting that occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an annual report) that has
materially affected, or is reasonably likely to materially affect, the registrants
internal control over financial reporting; and
 5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the registrants auditors and the
audit committee of the registrants board of directors (or persons performing the equivalent
functions):
 (a)
    
    All significant deficiencies and material weaknesses in the design or operation
of internal control over financial reporting which are reasonably likely to adversely
affect the registrants ability to record, process, summarize and report financial
information; and(b)
    
    Any fraud, whether or not material, that involves management or other employees
who have a significant role in the registrants internal control over financial
reporting.
 Date: September 9, 2005
    
    /s/ GORDON ELLISGordon EllisPresident and Chief Executive Officer
 25
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

# AGENCY:

Office of Minority Health, Office of the Assistant Secretary for Health, Office of the Secretary, Department of Health and Human Services.

# ACTION:

Notice: Correction.

# SUMMARY:

                        The Department of Health and Human Services published a notice in the                         **Federal Register**                         of December 21, 2010 announcing a meeting of the Advisory Committee on Minority Health. It was announced that this meeting would be held on Monday, January 10, 2011 from 9 a.m. to 5 p.m. and Tuesday, January 11, 2011 from 9 a.m. to 1 p.m. Due to unforseen circumstances the meeting date has been changed.                    

# FOR FURTHER INFORMATION CONTACT:

Ms. Monica A. Baltimore, Phone: 240-453-2882 Fax: 240-453-2883.

## Correction

                        In the                         **Federal Register**                         of December 21, 2010, Vol. 75, No. 244, on page 80055, in the 2nd column, correct the                         **DATES**                         caption to read:                    

The meeting will be held on Monday, February 21, 2011 from 9 a.m. to 5 p.m. and Tuesday, February 22, 2011 from 9 a.m. to 1 p.m.

      ( print page 147)    
Dated: December 28, 2010.

Mirtha Beadle,

Deputy Director, Office of Minority Health, Office of the Assistant Secretary for Health, Office of the Secretary, U.S. Department of Health and Human Services. 

[FR Doc. 2010-33084 Filed 12-30-10; 8:45 am]

BILLING CODE 4150-29-P
IN THE

TENTH COURT OF APPEALS

No. 10-11-00321-CV

EX PARTE TYLER DWAYNE CROWDER

From the 272nd District Court

Brazos County, Texas

Trial Court No. 11-000557-CV-272

MEMORANDUM OPINION

Appellant, the State of Texas has presented a motion to dismiss its appeal. The 

motion is granted.

This appeal is dismissed. TEX. R. APP. P. 42.1(a); 42.3(a).

TOM GRAY

Chief Justice

Before Chief Justice Gray,

Justice Davis, and

Justice Scoggins

Appeal dismissed

Opinion delivered and filed October 26, 2011

[CV06]
[Nos. 38409-1-I; 39160-7-I.

Division One.

November 17, 1997.]

#### Jeffrey G. Poole, et al., *Respondents,*v. Wally Olsen, *Defendant,*Helen Dore, *Appellant.*Jeffrey G. Poole, et al., *Respondents,*v. Wally Olsen, *Appellant,*Helen Dore, *Defendant.*

Appeals from a judgment of the Superior Court for Skagit County, No. 92-2-01195-9, Stanley K. Bruhn, J., entered March 11, 1995. *Reversed*by unpublished opinion per Cox, J., concurred in by Agid and Ellington, JJ.
Exhibit 99.2


               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                            AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


 In connection with the Quarterly Report of First Health Group Corp. (the
 "Company") on Form 10-Q for the period ended June 30, 2002, as filed with
 the Securities and Exchange Commission on the date hereof (the "Report"),
 I, Joseph E. Whitters, Chief Financial Officer of the Company, do hereby
 certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section
 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)  The Report fully complies with the requirements of Section 13(a)
 or 15(d) of the Securities Exchange Act of 1934; and

      (2)  The information contained in the Report fairly presents, in all
 material respects, the financial condition and results of operations of the
 Company.


 /s/ Joseph E. Whitters
 -----------------------
 Joseph E. Whitters
 Chief Financial Officer
 August 13, 2002
[No. 38528-3-I.

Division One.

December 1, 1997.]

#### The State of Washington, *Respondent,*v. Anthony V. Clark, *Appellant.*

Appeal from a judgment of the Superior Court for King County, No. 94-1-07641-4, Patricia H. Aitken, J., entered April 8,1996. *Affirmed*by unpublished per curiam opinion.
Exhibit 99.2


               CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
                            AS ADOPTED PURSUANT TO
                SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


 In connection with the Quarterly Report of First Health Group Corp. (the
 "Company") on Form 10-Q for the period ended September 30, 2002, as filed
 with the Securities and Exchange Commission on the date hereof (the
 "Report"), I, Joseph E. Whitters, Chief Financial Officer of the Company,
 do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant
 to Section 906 of the Sarbanes-Oxley Act of 2002, that:

      (1)  The Report fully complies with the requirements of Section 13(a)
 or 15(d) of the Securities Exchange Act of 1934; and

      (2)  The information contained in the Report fairly presents, in all
 material respects, the financial condition and results of operations of the
 Company.



 /s/ Joseph E. Whitters
 ----------------------
 Joseph E. Whitters
 Chief Financial Officer
 November 13, 2002
<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K
                                 CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934



Date of Report (Date of earliest event reported) August 6, 1998

                              THE LOEWEN GROUP INC.
             (Exact name of registrant as specified in its charter)



<TABLE>
<S>                                 <C>                         <C>       
    British Columbia, Canada                 0-18429                       98-0121376
-------------------------------     -----------------------     --------------------------------
(State or other jurisdiction of     (Commission File Number)    (IRS Employer Identification No.)
         incorporation)
</TABLE>




4126 Norland Avenue, Burnaby, British Columbia             V5G 3S8
  (Address of principal executive offices)                (zip code)



Registrant's telephone number, including area code  604-299-9321



                                       N/A
--------------------------------------------------------------------------------
          (Former name or former address, if changed since last report)



                                                      Exhibit Index is on page 3
                                                                     Page 1 of 6
<PAGE>   2
ITEM 5.    OTHER EVENTS.

Pursuant to Form 8-K, General Instructions F, registrant hereby incorporates by
reference the press release attached hereto as Exhibit 99.


ITEM 7.    FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.

           Exhibit No.      Description

           Exhibit 99       The Loewen Group Inc. Press Release dated August 
                            6, 1998


                                   SIGNATURES

               Pursuant to the requirements of the Securities Exchange Act of
1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Dated: August 6, 1998

                                       THE LOEWEN GROUP INC.



                                       By: /s/ BRADLEY D. STAM
                                           -------------------------------------
                                           Name: Bradley D. Stam
                                           Title:   Senior Vice-President, Law

<PAGE>   3
                                  EXHIBIT INDEX



<TABLE>
<CAPTION>
                                                                      Sequential
Number         Exhibit                                                Page Number
------         -------                                                -----------
<S>            <C>                                                    <C>
99             The Loewen Group Inc.                                       4
               Press Release dated August 6, 1998
</TABLE>
Order entered November 14, 2019

In The 

## Court of Appeals Fifth District of Texas at Dallas

No. 05

- 19

- 01304

- CV

LG ELECTRONICS U.S.A ., INC., Appellant

V.

LOVERS TRADITION II, LP, Appellee

On Appeal from the 134th Judicial District Court

Dallas County, Texas Trial Court Cause No. DC

- 17

- 09593



### O RDER

Before the Court are appellant’s November 4, 2019 opposed motion to stay or abate
appeal and court reporter Tina Thompson’s November 6, 2019 request for an extension of time

to file the record. We DENY the motion to stay. We GRANT the reporter’s extension request

and ORDER the reporter’s record received November 12, 2019 filed as of the date of this order.
As the appellate record appears complete, we ORD ER appellant to file its opening brief

no later than December 4 , 2019.

/s/ BILL WHITEHILL JUSTICE
§ 1312.21 Requirement of authorization to export. ( a ) No person shall in any manner export, or cause to be exported, from the United States any controlled substance listed in Schedule I or II, or any narcotic controlled substance listed in Schedule III or IV, or any non-narcotic controlled substance in Schedule III which the Administrator has specifically designated by regulation in § 1312.30 or any non-narcotic controlled substance in Schedule IV or V which is also listed in Schedule I or II of the Convention on Psychotropic Substances, 1971, unless and until such person is properly registered under the Act (or, in accordance with part 1301 of this chapter, exempt from registration) and the Administrator has issued him or her a permit to do so in accordance with § 1312.23.
( b ) No person shall in any manner export, or cause to be exported, from the United States any non-narcotic controlled substance listed in Schedule III, IV, or V, excluding those described in paragraph (a) of this section, or any narcotic controlled substance listed in Schedule V, unless and until such person is properly registered under the Act (or, in accordance with part 1301 of this chapter, exempt from registration) and has furnished an export declaration as provided by section 1003 of the Act (21 U.S.C. 953(e)) to the Administration in accordance with § 1312.28.
( c ) A separate permit or declaration is required for each shipment of controlled substance to be exported.
[81 FR 97029, Dec. 30, 2016]
BrentR. Cole Law Office ofBrent R. Cole, P.C. 821 N Street, Suite 208 Anchorage, AK 99501 (907) 277-8001 Attorneys for Redemption Air, Inc. U.S. DEPARTMENT OF TRANSPORTATION OFFICE OF HEARINGS WASHINGTON, DC In the matter of: Redemption Air, Inc. ) ) FAA Case No. 2013AL030106 ) Docket No. FAA-2014-0115

______________ ) (Civil PenaltyAction) MOTION TO COMPEL DISCOVERY. IMPOSE SANCTIONS, AND ORDERREDEMPTION AIR BE REIMBURSED Comes now Redemption Air, Inc. ("Redemption Air"), by and through counsel of record, the Law Office of Brent R. Cole, P.C., and moves this Court for an order compelling the Federal Aviation Administration ("FAA") to make Christina Bryant (Ms. Bryant") available to be deposed pursuant to 13 CFR 

### § 13.2200) or, in the alternative, impose sanctions precluding her testimony or evidence ofher testimony at the hearing pursuant to 13 CFR § 13.220(n). Further, this Court shouldrequire the FAA to reimburse Redemption Air for expenses incurred as a result ofMs. Bryant's failure to appear at the time and location for her previously scheduled deposition. This motion is supported by a memorandum of law filed concurrently herewith. A proposed order is attached for the Court's convenience.

Motion to Compel Discovery, Impose Sanctions, and OrderRedemption Airbe Reimbursed In re: RedemptionAir, Inc., DocketNo. FAA-2014-0115 Page I of2

### DATED this

# Jr. day ofDecember, 2014, at Anchorage, Alaska.

was ®Mailed '\ [J Hand-delivered -!- Q_II'\IM 1:)11 Faxed to the following: Original and one copy: Attention; Hearing Docket Clerk, AGC-430 Wilbur Wright Building-Suite2WIOOO Federal Aviation Administration 800 Independence Avenue, SW Washington, DC 20591 Onecopy: Craig Wm. Black, Esq. Office ofthe Regional Counsel 222 West 7th Avenue, #14 Anchorage, AK 99513-7587 Craig.B1ack@faa.gov Fax: 271-2800
The Honorable Richard C. Goodwin, Administrative Law Judge Office ofHearings, M-20 U.S. Department ofTransportation 1200 New Jersey Avenue, S.E. (EII-310) Washington, DC 20590 Richard.Goodwin@dot.gov

## Faxn2-366-75~**rtJJJ~**

# Ca~

Motion to Compel Discovery, Impose Sanctions, and OrderRedemption Airbe Reimbursed

### LAW OFFICE OF BRENT R. COLE, P.C. Attorneys for Redemption Air, Inc.

# By:~ 

# Cc... BrentR. Cole AK State BarNo. 8606074

In re: RedemptionAir, Inc., Docket No. FAA-2014-0115 Page 2 of2
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of the Interior

###### Bureau of Land Management

          - [F-14931-B; LLAK964000-L14100000-HY0000-P]

# AGENCY:

Bureau of Land Management, Interior.

# ACTION:

Notice of decision approving lands for conveyance.

# SUMMARY:

As required by 43 CFR 2650.7(d), notice is hereby given that an appealable decision approving the surface estate in certain lands for conveyance pursuant to the Alaska Native Claims Settlement Act will be issued to Zho-Tse, Incorporated. The lands are in the vicinity of Shageluk, Alaska, and are located in:

## Seward Meridian, Alaska

T. 28 N., R. 55 W.,

Sec. 29, lots 6 and 7.

Containing 338.77 acres.

The subsurface estate in these lands will be conveyed to Doyon, Limited, when the surface estate is conveyed to Zho-Tse, Incorporated. Notice of the decision will also be published four times in the Fairbanks Daily News-Miner.

# DATES:

The time limits for filing an appeal are:

1. Any party claiming a property interest which is adversely affected by the decision shall have until March 25, 2010 to file an appeal.

2. Parties receiving service of the decision by certified mail shall have 30 days from the date of receipt to file an appeal.

Parties who do not file an appeal in accordance with the requirements of 43 CFR part 4, subpart E, shall be deemed to have waived their rights.

# ADDRESSES:

A copy of the decision may be obtained from: Bureau of Land Management, Alaska State Office, 222 West Seventh Avenue, #13, Anchorage, Alaska 99513-7504.

# FOR FURTHER INFORMATION, CONTACT:

                        The Bureau of Land Management by phone at 907-271-5960, or by e-mail at                         *ak.blm.conveyance@ak.blm.gov.*                         Persons who use a telecommunication device (TTD) may call the Federal Information Relay Service (FIRS) at 1-800-877-8339, 24 hours a day, seven days a week, to contact the Bureau of Land Management.                    

Barbara Opp Waldal,

Land Law Examiner, Land Transfer Adjudication I Branch.

[FR Doc. 2010-3418 Filed 2-22-10; 8:45 am]

BILLING CODE 4310-JA-P
#### § 1305.01 Scope of part 1305.

Procedures governing the issuance, use, and preservation of orders for Schedule I and II controlled substances are set forth generally by section 308 of the Act (21 U.S.C. 828) and specifically by the sections of this part.
§ 1305.21 Requirements for electronic orders. ( a ) To be valid, the purchaser must sign an electronic order for a Schedule I or II controlled substance with a digital signature issued to the purchaser, or the purchaser's agent, by DEA as provided in part 1311 of this chapter.
( b ) The following data fields must be included on an electronic order for Schedule I and II controlled substances: ( 1 ) A unique number the purchaser assigns to track the order. The number must be in the following 9-character format: the last two digits of the year, X, and six characters as selected by the purchaser.
( 2 ) The purchaser's DEA registration number.
( 3 ) The name of the supplier.
( 4 ) The complete address of the supplier (may be completed by either the purchaser or the supplier).
( 5 ) The supplier's DEA registration number (may be completed by either the purchaser or the supplier).
( 6 ) The date the order is signed.
( 7 ) The name (including strength where appropriate) of the controlled substance product or the National Drug Code (NDC) number (the NDC number may be completed by either the purchaser or the supplier).
( 8 ) The quantity in a single package or container.
( 9 ) The number of packages or containers of each item ordered.
( c ) An electronic order may include controlled substances that are not in schedules I and II and non-controlled substances.
§ 1.1410 When will FDA consider whether to waive a requirement of this subpart? FDA will consider whether to waive a requirement of this subpart on our own initiative or in response to the following: ( a ) A written request for a waiver for an individual entity; or
( b ) A citizen petition requesting a waiver for a type of entity submitted under § 10.30 of this chapter by any person subject to the requirements of this subpart.